Correlation of histopathologic features of ductal carcinoma in situ of the breast with the oncotype DX DCIS score

Rakovitch, 2007, The management of ductal carcinoma in situ of the breast: a screened population-based analysis, Breast Cancer Res Treat, 101, 429, 10.1007/s10549-006-9302-0 Fisher, 1999, Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight year update of Protocol B-17, Cancer, 86, 429, 10.1002/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO;2-Y Wapnir, 2011, Long term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS, J Natl Cancer Inst, 103, 478, 10.1093/jnci/djr027 Fisher, 1998, Lumpectomy and radiation therapy for the treatment of intraductal cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17, J Clin Oncol, 16, 441, 10.1200/JCO.1998.16.2.441 Gradishar WJ, Anderson BO, Balassanian R et al NCCN Clinical Practice Guidelines in Oncology: Breast cancer http://www.nccn.org/professions/physiciansgls/pdf/breast.pdf.Version1.2014. Goodwin, 2009, Post-operative radiotherapy for ductal carcinoma in situ of the breast-a systemic review of the randomized trials, Breast, 18, 143, 10.1016/j.breast.2009.04.003 Hughes, 2009, Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group, J Clin Oncol, 27, 5319, 10.1200/JCO.2009.21.8560 Motwani, 2011, Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194, Cancer, 177, 1156, 10.1002/cncr.25623 Early Breast Cancer Trialist's Collaborative Group (EBCTCG), 2010, Overview of the randomized trials of radiotherapy in ductal carcinoma in situ, J Natl Cancer Inst Monogr, 41, 162, 10.1093/jncimonographs/lgq039 Solin, 2013, A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast, J Natl Cancer Inst, 105, 701, 10.1093/jnci/djt067 Rakovitch E . Oncotype DX DCIS score predicts recurrence. Cancer Discov. 2014;5: OF3 Published online first, 23 December 2014. Fang, 2013, Association of the glutathione s-transferase M1, T1 polymorphisms with cancer: evidence from a meta-analysis, PLOS One, 8, e78707, 10.1371/journal.pone.0078707 Badve S, Gray R, Baehner F et al. Correlation between the DCIS score and traditional clinicopathologic features in the prospectively designed E5194 clinical validation study. J Clin Oncol 2012;30, (suppl;abstr 1005). Elston, 1991, Pathologic prognostic factors in breast cancer: the value of histologic grade in breast cancer:experience from a large study with long-term follow-up, Histopathology, 19, 403, 10.1111/j.1365-2559.1991.tb00229.x Lester S, Bose S, Chen Y et al Protocol for the examination of specimens from patients with DCIS of the breast http://www.cap.org/cancerprotocols Dec 2013. Lari, 2011, Biologic markers in DCIS and risk of breast recurrence: a systemic review, J Cancer, 2, 232, 10.7150/jca.2.232 Allen, 2014, Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high risk patients and predicts recurrence, Clin Cancer Res, 20, 344, 10.1158/1078-0432.CCR-13-1504 Cowell, 2013, Progression form ductal carcinoma insitu to invasive breast cancer: revisited, Mol Oncol, 7, 859, 10.1016/j.molonc.2013.07.005 Ma, 2009, Gene expression profiling of the tumor microenvironment during breast cancer progression, Breast Cancer Res, 11, R7, 10.1186/bcr2222 Salgado, 2014, Harmonization of the evaluation of tumor infiltrating lymphocytes (TIL) in breast cancer: recommendations by an international TILs working group 2014, Ann Clin Oncol, 00, 1